ArticlePediatric radiology2026
Utilizing a chest CT interstitial lung disease scoring system for commonly encountered pediatric rheumatologic diseases with associated interstitial lung disease with clinical correlation.
Article in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChest CT is useful for early detection and monitoring of rheumatologic-related interstitial lung disease (ILD) in children. However, interpretation is inconsistent and lacks standardization.
objectiveThis study employs prior disease-specific CT scoring systems to systematically assess most rheumatologic diseases with ILD in pediatric patients and correlate scores with clinical findings. MATERIALS AND
methodsThis retrospective study included patients (ages 0-21 years) with rheumatologic-related ILD and chest CT. Two pediatric radiologists determined CT quality and separated patients into disease and disease control groups. Three different blinded pediatric radiologists scored CT scans using this Pediatric Rheumatologic Interstitial Lung Disease (PRILD) scoring system, comprising of parenchymal, nodule/mass/cavitary/cyst, and pleural/pericardial components (total score, 125). Clinical data were extracted from medical records. Non-parametric tests were used for group comparisons, intraclass correlation coefficient (ICC) for interobserver agreement, and Spearman's correlation for CT and pulmonary function relationships.
resultsMedian age was 13.8 years and 84% were female. The disease group had statistically significant higher median total PRILD scores than the disease control group (7.3 vs. 1.7, P<0.001) and a higher percent active rheumatologic disease (93% vs 78%, P=0.039). There were no statistically significant differences between the two groups regarding age, sex, rheumatologic disease type, disease duration, or pulmonary symptoms. Interrater agreement was poor; ICC was 0.41. When both groups were combined, there were weak negative correlations with pulmonary function tests.
conclusionPRILD scoring system aids in systematic evaluation of thoracic involvement in rheumatologic-related ILD. However, further refinement and education are needed to improve interrater agreement, and given the rare nature of these diseases, a multicenter collaboration is necessary for validation of this CT scoring system.
Indexed as
Identifiers
42287423What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.